Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

Thematic (Sector/Industry)

<ul>
<li>We discuss the share price performances of the top 50 F&amp;B companies in Korea and whether these Korean F&amp;B companies could continue to outperform the market amid higher inflation rates.</li>
<li>In general, we do believe that the Korean F&amp;B sector as a whole could continue to outperform the market in times of higher inflation rates. </li>
<li>The F&amp;B sector tends to have lower sensitivity to demand relative to higher product prices and many of them can generally offset higher raw material costs with higher product prices. </li>
</ul>


We discuss the share price performances of the top 50 F&amp;B companies in Korea and whether these Korean F&amp;B companies could continue to outperform the market amid higher inflation rates.
In general, we do believe that the Korean F&amp;B sector as a whole could continue to outperform the market in times of higher inflation rates. 
The F&amp;B sector tends to have lower sensitivity to demand relative to higher product prices and many of them can generally offset higher raw material costs with higher product prices. 


Korean Food & Beverage: An Outperforming Sector Beating Inflation & KOSPI

<ul>
<li>In this insight, we discuss the transition from the COVID-19 pandemic to "live with" COVID-19 endemic in Korea and the impact this will have on the reopening plays in Korea.</li>
<li>In many parts of the world in countries such as the U.K. and Denmark, numerous stringent mandates and restrictions related to COVID-19 have been removed.</li>
<li>The pandemic to endemic reopening could increasingly become a world-wide trend including in Korea and the 17 stocks highlighted in this insight could continue to outperform the market. </li>
</ul>


In this insight, we discuss the transition from the COVID-19 pandemic to "live with" COVID-19 endemic in Korea and the impact this will have on the reopening plays in Korea.
In many parts of the world in countries such as the U.K. and Denmark, numerous stringent mandates and restrictions related to COVID-19 have been removed.
The pandemic to endemic reopening could increasingly become a world-wide trend including in Korea and the 17 stocks highlighted in this insight could continue to outperform the market. 


Pandemic to Endemic Reopening Plays in Korea

Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

Shenton Research

Shenton Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Quantitative Analysis

<ul>
<li>We analyzed the changes in short interest of KRX stocks as of Jul 17th. The aggregated short interest was USD15.1bn.</li>
<li>We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in TES, ISUPETASYS, PSK, Samsung Electronics, Samsung F&amp;M Insurance.</li>
</ul>


We analyzed the changes in short interest of KRX stocks as of Jul 17th. The aggregated short interest was USD15.1bn.
We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in TES, ISUPETASYS, PSK, Samsung Electronics, Samsung F&amp;M Insurance.


KRX Short Interest Weekly (Jul 17th): TES, ISUPETASYS, PSK, Samsung Electronics

Global Special Situations & Strategy, SR Services Ltd

David Lepper

Global Special Situations & Strategy

SR Services Ltd

SR Services provides Strategic Knowledge and Solutions services for Family Offices and Corporate Business. 

We deliver this via advisory services, strategic planning, opportunity analysis/sourcing, as well as solution implementation. 

Whilst, we create intellectual discipline and operational leverage for your projects or daily activities, our ultimate objective is to empower whilst enhancing your decision making. 

Strategic Knowledge and Solutions

Cross Asset Strategy

<ul>
<li>
Our Q3-2021 All Cap High-Risk screen of stocks produced a market-cap-weighted average price return of 2% and a simple average decline of 0.2%.</li>
<li>
Out of the 34 stocks that appeared in our Q3-2021 screen, 15 stocks saw an average share price decline of 11.5%, whilst 19 stocks appreciated on average by 14%. The two biggest declining stock  were down 25% and 19% respectively.</li>
<li>Our Q4 2021 screen, with 38 names (up from 34 seen in Q3 and Q2 2021) delivers an interesting composition this quarter, </li>
<li>
As in the previous few quarters, we anticipate the possibility of a risk of deteriorating credit metrics during the next few quarters: Q4 2021’s Altman Z score rests at 1.23, which is just up on Q3 2021’s level of 1.19.</li>
</ul>



Our Q3-2021 All Cap High-Risk screen of stocks produced a market-cap-weighted average price return of 2% and a simple average decline of 0.2%.

Out of the 34 stocks that appeared in our Q3-2021 screen, 15 stocks saw an average share price decline of 11.5%, whilst 19 stocks appreciated on average by 14%. The two biggest declining stock  were down 25% and 19% respectively.
Our Q4 2021 screen, with 38 names (up from 34 seen in Q3 and Q2 2021) delivers an interesting composition this quarter, 

As in the previous few quarters, we anticipate the possibility of a risk of deteriorating credit metrics during the next few quarters: Q4 2021’s Altman Z score rests at 1.23, which is just up on Q3 2021’s level of 1.19.


Screening the Silk Road: Q4 2021 High-Risk Names to Avoid

<h2>Eight new names, SoftBank remains for the 3rd quarter running</h2>
<ul>
<li>
OurQ2-2021 All Cap High-Risk screen of stocks produced a market cap-weighted average price decline of 2%. In comparison, the MSCI Asia Pacific Index posted a decline of 1.7% over the same period. The stock quality of our Q2 2021 decreased 2.4 points or 3.8% over the period. Within the mix of 34 stocks in our Q2 2021 (May) list 19 posted negative performance, with an average decline of 14.1%.</li>
<li>
At a static number of 34 stocks our Q3 2021 screen, delivers an interesting composition this quarter, with eight (8) new names and strong representation from Hong Kong in terms of geography and Industrials and Basic Materials from a sector perspective. This suggests that the “reopening of the economy” trade may have run its course for now.</li>
<li>Our Q3 2021 screen shows a further reduction in average stock rank (a reading on relative quality amongst the broad market peers with 100 being the highest) to 61 from 65.18 in Q2 2021.</li>
<li>
Stock specific focus: We discuss why SoftBank stands out as a stock that presents with additional risk. We also discuss the fact that whilst there is a high representation of Industrials in the list, within this list, there are several names that may warrant not being too bearish towards.</li>
</ul>

Eight new names, SoftBank remains for the 3rd quarter running


OurQ2-2021 All Cap High-Risk screen of stocks produced a market cap-weighted average price decline of 2%. In comparison, the MSCI Asia Pacific Index posted a decline of 1.7% over the same period. The stock quality of our Q2 2021 decreased 2.4 points or 3.8% over the period. Within the mix of 34 stocks in our Q2 2021 (May) list 19 posted negative performance, with an average decline of 14.1%.

At a static number of 34 stocks our Q3 2021 screen, delivers an interesting composition this quarter, with eight (8) new names and strong representation from Hong Kong in terms of geography and Industrials and Basic Materials from a sector perspective. This suggests that the “reopening of the economy” trade may have run its course for now.
Our Q3 2021 screen shows a further reduction in average stock rank (a reading on relative quality amongst the broad market peers with 100 being the highest) to 61 from 65.18 in Q2 2021.

Stock specific focus: We discuss why SoftBank stands out as a stock that presents with additional risk. We also discuss the fact that whilst there is a high representation of Industrials in the list, within this list, there are several names that may warrant not being too bearish towards.


Screening the Silk Road: Q3 2021 High-Risk Names to Avoid

South Korea

Hite Jinro Co., Ltd. specializes in manufacturing Soju, vodka-like distilled Korean liquor. The Company also produces and sells other alcoholic beverages, such as wine, whiskey, and ginseng liquors as well as non-alcoholic beverages including mineral water and soft drinks. In addition, Jinro also provides information processing and financial services as well as construction services.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Hite Jinro (000080 KS)

Korean Food & Beverage: An Outperforming Sector Beating Inflation & KOSPI

In this insight, we discuss the share price performances of the top 50 F&B companies in Korea and whether these Korean F&B companies could continue...

Douglas Kim

Pandemic to Endemic Reopening Plays in Korea

The pandemic to endemic reopening could increasingly become a world-wide trend including in Korea and the 17 stocks highlighted in this insight...

Douglas Kim

KRX Short Interest Weekly (Jul 17th): TES, ISUPETASYS, PSK, Samsung Electronics

We analyzed KRX short interest report for the past week and highlighted short interest changes in TES, ISUPETASYS, PSK, Samsung Electronics,...

Ke Yan, CFA, FRM

Screening the Silk Road: Q4 2021 High-Risk Names to Avoid

As we move through into Q1 2022, we expect to see volatility around highly priced & leveraged names. This screen is a key starting point towards...

David Lepper

Screening the Silk Road: Q3 2021 High-Risk Names to Avoid

Screening the Silk Road Q3 2021: Asia Pac High-risk names to avoid screening is out now. Eight new names, despite being down 23%, SoftBank remains...

David Lepper

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)